Francisco Lopez-Munoz

Editorial Board Member

Professor of Pharmacology, Camilo José Cela University, Spain

Contact Francisco Lopez-Munoz

Department / University Information


Francisco López-Muñoz, MD, PhD, DLitt, received his PhD Degree in Medicine at Madrid Complutense University in 1993 (Doctorate Extraordinary Award), and another PhD Degree in Spanish Language and Literature at University of Alcalá in 2015. Currently he is Professor of Pharmacology, Director of International Doctorate School, Chairman of the Research Ethics Committee, and Assistant Director of Academic Staff at Camilo José Cela University, and Research Fellow at “Hospital 12 de Octubre” Research Institute (Madrid, Spain), and Portucalense Institute of Neuropsychology and Cognitive and Behavioral Neurosciences (INPP), Universidade Portucalense Infante Dom Henrique (Porto, Portugal). He has supervised 13 PhD theses, has participated in 26 research projects, and acts as evaluator of research projects and degrees for several European Agencies. Dr. López-Muñoz is editor/author of 25 books, and 209 chapters of books related to the psychopharmacology. He has published 335 articles (H-index = 27). Dr. López-Muñoz is member of several scientific societies (including CINP) and editorial boards, and has participated, as visiting Professor in different Spanish and international academic centres. Dr. López-Muñoz has various awards for his research career, and he is Academician of the Royal European Academy of Doctors and Correspondent Academician of the Royal Academy of Medicine and Surgery of Cádiz, and Royal Academy of History and Art of San Quirce.

Research Interest

Neuropsychopharmacology and Neurosciences: Biological bases of drug abuse and dual diagnosis, psychotropic drugs interactions, neurobiology of metal disorders, bibliometric techniques applied to mental health-related disciplines and neuropsychopharmacology, combination therapies with antidepressant drugs in resistant depression and with antipsychotics drugs in patients with refractory schizophrenia, and the history of the psychopharmacology and neurosciences.